The expression of proliferating cell nuclear antigen (PCNA), a key regulator in cell cycle control, DNA replication and repair, is strongly upregulated in many chronic myelogenous leukaemia (CML) patients. Here, PCNA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.